Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal
- PMID: 16103361
- PMCID: PMC1189351
- DOI: 10.1073/pnas.0505714102
Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal
Abstract
Acetyl-CoA carboxylases (ACC1 and ACC2) catalyze the carboxylation of acetyl-CoA to form malonyl-CoA, an intermediate metabolite that plays a pivotal role in the regulation of fatty acid metabolism. We previously reported that ACC2 null mice are viable, and that ACC2 plays an important role in the regulation of fatty acid oxidation through the inhibition of carnitine palmitoyltransferase I, a mitochondrial component of the fatty-acyl shuttle system. Herein, we used gene targeting to knock out the ACC1 gene. The heterozygous mutant mice (Acc1(+/-)) had normal fertility and lifespans and maintained a similar body weight to that of their wild-type cohorts. The mRNA level of ACC1 in the tissues of Acc1(+/-) mice was half that of the wild type; however, the protein level of ACC1 and the total malonyl-CoA level were similar. In addition, there was no difference in the acetate incorporation into fatty acids nor in the fatty acid oxidation between the hepatocytes of Acc1(+/-) mice and those of the wild type. In contrast to Acc2(-/-) mice, Acc1(-/-) mice were not detected after mating. Timed pregnancies of heterozygotes revealed that Acc(-/-) embryos are already undeveloped at embryonic day (E)7.5, they die by E8.5, and are completely resorbed at E11.5. Our previous results of the ACC2 knockout mice and current studies of ACC1 knockout mice further confirm our hypotheses that malonyl-CoA exists in two independent pools, and that ACC1 and ACC2 have distinct roles in fatty acid metabolism.
Figures






Similar articles
-
Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice.Mol Cell Biol. 2007 Mar;27(5):1881-8. doi: 10.1128/MCB.01122-06. Epub 2007 Jan 8. Mol Cell Biol. 2007. PMID: 17210641 Free PMC article.
-
Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2.Science. 2001 Mar 30;291(5513):2613-6. doi: 10.1126/science.1056843. Science. 2001. PMID: 11283375
-
Glucose and fat metabolism in adipose tissue of acetyl-CoA carboxylase 2 knockout mice.Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1384-9. doi: 10.1073/pnas.0409451102. Epub 2005 Jan 26. Proc Natl Acad Sci U S A. 2005. PMID: 15677334 Free PMC article.
-
Acetyl-CoA Carboxylases and Diseases.Front Oncol. 2022 Mar 11;12:836058. doi: 10.3389/fonc.2022.836058. eCollection 2022. Front Oncol. 2022. PMID: 35359351 Free PMC article. Review.
-
Acetyl-CoA carboxylase inhibition for the treatment of metabolic syndrome.Curr Opin Investig Drugs. 2004 Mar;5(3):283-9. Curr Opin Investig Drugs. 2004. PMID: 15083594 Review.
Cited by
-
Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome.Endocrine. 2006 Feb;29(1):91-100. doi: 10.1385/ENDO:29:1:91. Endocrine. 2006. PMID: 16622296 Review.
-
Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models.Emerg Microbes Infect. 2019;8(1):624-636. doi: 10.1080/22221751.2019.1604084. Emerg Microbes Infect. 2019. PMID: 30999821 Free PMC article.
-
AMPK-ACC signaling modulates platelet phospholipids and potentiates thrombus formation.Blood. 2018 Sep 13;132(11):1180-1192. doi: 10.1182/blood-2018-02-831503. Epub 2018 Jul 17. Blood. 2018. PMID: 30018077 Free PMC article.
-
Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation.Biochem Pharmacol. 2011 Mar 1;81(5):649-60. doi: 10.1016/j.bcp.2010.12.014. Epub 2010 Dec 22. Biochem Pharmacol. 2011. PMID: 21184748 Free PMC article.
-
Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2.J Clin Invest. 2006 Mar;116(3):817-24. doi: 10.1172/JCI27300. Epub 2006 Feb 16. J Clin Invest. 2006. PMID: 16485039 Free PMC article.
References
-
- Prentki, M., Joly, E., El-Assaad, W. & Roduit, R. (2002) Diabetes 51, S405–S413. - PubMed
-
- Roduit, R., Nolan, C., Alarcon, C., Moore, P., Barbeau, A., Delghingaro-Augusto, V., Przybykowski, E., Morin, J., Masse, F., Massie, B., et al. (2004) Diabetes 53, 1007–1019. - PubMed
-
- McGarry, J. D. & Brown, N. F. (1997) Eur. J. Biochem. 244, 1–14. - PubMed
-
- Abu-Elheiga, L., Matzuk, M. M., Abo-Hashema, K. A. H. & Wakil, S. J. (2001) Science 291, 2613–2616. - PubMed
-
- Lopaschuk, G. & Gamble, J. (1994) Can. J. Physiol. Pharmacol. 72, 1101–1109. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous